All news

Poland legalizes medical marijuana

Yesterday, President Duda signed Poland’s medical cannabis bill into law, making Poland the latest European Union member country to permit the use of medical marijuana. Cannabis reform in Poland has moved fast and steady in the last couple of months.

New research shows cannabidiol (CBD) reduces incision pain

New studies seem to suggest that CBD could be used directly in the control of pain associated with incisions

Forget the US. Here's where medical marijuana is really taking off

Medical marijuana still faces many hurdles in the U.S. There's an even bigger market that is ripe for investment, says CEO Benjamin Ward.

Cannabics Pharmaceuticals Inc expands development of cannabinoid based treatments

The cannabis sector itself is beginning to see as big of an upturn as it did late last year and early this year, after a period of many months demonstrated a pronounced lag in most pot-related plays.

Could cannabidiol be used to treat ASIA syndrome?

With autoimmune disorders on the rise and standard treatments rendered ineffective, it might be time to look for an alternative solution, such as CBD

Marijuana stigma hurts doctor–patient relationship, study says

The fear of being labeled a "stoner" can make some patients leave painful symptoms untreated. Others may avoid the doctor entirely.

Kosher kush: The Orthodox-approved pot brownie

California couple offers medical cannabis edibles, but Orthodox Union makes it clear that it draws the line at recreational use.

iAnthus Enters The New York Cannabis Market; Does The $17.3 Million Acquisition Make Sense?

Earlier this month, cannabis-focused financing and advisory firm iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF) announced it acquired Westchester-based Valley Agriceuticals...

Patients find freedom from fibromyalgia pain with cannabis

When I first met Vicki, I connected with her right away. Comfortable in her own skin, I knew that if it weren’t for our professional relationship, we might have been friends.


GB Sciences to test cannabis-based therapies on human, taps Worldwide Clinical Trials

GB Sciences has decided to focus its drug development forces on three cannabinoid therapies in its pipeline, and it has tapped Worldwide Clinical Trials to assess its intellectual property portfolio and to help with pre-IND planning.